Get the Stockscreener App
0.00
100.00%
-1.27
After Hours:
1.28
1.28
+
Igm Biosciences Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.
See More
Previous Close:
$1.27
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$76.57M
Revenue:
$2.91M
Net Income/Loss:
$-220.40M
P/E Ratio:
0.00
EPS:
-3.64
Net Cash Flow:
$-176.15M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$8.55
Igm Biosciences Inc Stock (IGMS) Company Profile
Name
Igm Biosciences Inc
Sector
Industry
Phone
650-965-7873
Address
325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW
Compare IGMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IGMS
Igm Biosciences Inc
|
0.00 | 76.57M | 2.91M | -220.40M | -176.15M | -3.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-10-25 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-10-25 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-10-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-10-25 | Downgrade | Stifel | Buy → Hold |
| Dec-06-24 | Initiated | BMO Capital Markets | Outperform |
| Oct-01-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-24 | Downgrade | Truist | Buy → Hold |
| Feb-09-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-15-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-07-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-09-22 | Resumed | Jefferies | Buy |
| Oct-17-22 | Initiated | JP Morgan | Neutral |
| Aug-29-22 | Initiated | BofA Securities | Buy |
| Dec-13-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-05-21 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-26-21 | Initiated | Morgan Stanley | Overweight |
| Jan-29-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-19-21 | Reiterated | H.C. Wainwright | Buy |
| Dec-22-20 | Downgrade | Wedbush | Outperform → Neutral |
| Jul-17-20 | Initiated | Robert W. Baird | Outperform |
| Jul-01-20 | Initiated | H.C. Wainwright | Buy |
| May-28-20 | Initiated | SunTrust | Buy |
| Apr-22-20 | Initiated | Wedbush | Outperform |
| Oct-14-19 | Initiated | Guggenheim | Buy |
| Oct-14-19 | Initiated | Jefferies | Buy |
| Oct-14-19 | Initiated | Piper Jaffray | Overweight |
| Oct-14-19 | Initiated | Stifel | Buy |
View All
Igm Biosciences Inc Stock (IGMS) Latest News
Will Shree Hanuman Sugar Industries Limited Benefit From Sector TailwindsDividend Stock Watch & Market Monitoring and Alerts - earlytimes.in
How strong dollar benefits IGM Biosciences Inc. (1K0) stockWeekly Profit Analysis & Free Daily Entry Point Trade Alerts - Newser
Can IGM Biosciences Inc. (1K0) stock deliver consistent EPS growth2025 Bull vs Bear & Consistent Return Investment Signals - Newser
Will IGM Biosciences Inc. (1K0) stock beat international competitionTrade Ideas & Real-Time Chart Breakout Alerts - Newser
Why IGM Biosciences Inc. (1K0) stock could be top winnerProduct Launch & Fast Entry Momentum Alerts - Newser
Will IGM Biosciences Inc. (1K0) stock hit analyst forecastsPortfolio Performance Report & High Accuracy Buy Signal Tips - Newser
Will IGM Biosciences Inc. (1K0) stock attract long term capital inflowsShare Buyback & Stock Portfolio Risk Management - newser.com
Why IGM Biosciences Inc. stock is favored by pension fundsTrade Risk Assessment & High Win Rate Trade Alerts - newser.com
IGM Biosciences Inc. stock trend forecastWeekly Trend Recap & Low Risk Profit Maximizing Plans - newser.com
Will IGM Biosciences Inc. stock deliver better than expected guidanceJuly 2025 Intraday Action & Verified Swing Trading Watchlists - newser.com
How strong is IGM Biosciences Inc. (1K0) stock earnings growth2025 Market Trends & Weekly High Return Stock Forecasts - newser.com
What valuation multiples suggest for IGM Biosciences Inc. stock2025 Short Interest & Safe Swing Trade Setup Alerts - newser.com
Is IGM Biosciences Inc. stock cheap at current valuationDollar Strength & Long-Term Capital Growth Strategies - newser.com
Will IGM Biosciences Inc. stock rally after Fed decisionsWeekly Stock Summary & Weekly High Potential Alerts - newser.com
Why IGM Biosciences Inc. (1K0) stock could be next leaderQuarterly Growth Report & AI Forecast for Swing Trade Picks - newser.com
Historical volatility pattern of IGM Biosciences Inc. visualizedProduct Launch & AI Powered Market Entry Ideas - newser.com
Will IGM Biosciences Inc. stock keep outperforming rivals2025 Retail Activity & Free Accurate Trade Setup Notifications - newser.com
What moving averages say about IGM Biosciences Inc.Analyst Upgrade & High Accuracy Swing Trade Signals - newser.com
Why retail investors pile into IGM Biosciences Inc. stockJuly 2025 Outlook & Stepwise Trade Signal Implementation - newser.com
What analysts say about IGM Biosciences Inc stockInsider Trading Compliance & Access Free Tools and Start Investing - earlytimes.in
Visual analytics tools that track IGM Biosciences Inc. performanceVolume Spike & Community Trade Idea Sharing - newser.com
Igm Biosciences Inc Stock (IGMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):